...
krbp-img

Kiromic Biopharma Inc, Common Stock

KRBP

PNK

$0.95

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.69M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.77K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.98
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.28 L
$3.78 H
$0.95

About Kiromic Biopharma Inc, Common Stock

Kiromic BioPharma, Inc., a clinical stage biotherapeutics company, utilizes engineered and non-engineered Gamma Delta T cell (GDT) technologies to develop therapies for solid tumors. The company develops Deltacel-01, which is in Phase 1 clinical trial, for patients with non-small cell lung cancer; Isocel in combination with low-dose radiation to treat Mesothelin Isoform 2 positive solid malignancies; ALEXIS-ISO-1, an allogeneic GDT therapy product that targets an isoform of mesothelin; Procel in combination with low-dose radiation to treat PD-L1 positive solid malignancies; and ALEXIS-PRO-1, an allogeneic GDT therapy product that targets PD-L1. It has a license agreement with Longwood University; and a research and development collaboration agreement with Molipharma, S.R.L. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameKRBPSectorS&P500
1-Week Return--2.82%0.15%
1-Month Return-2.06%-4.22%1.78%
3-Month Return-52.85%-9.52%8.7%
6-Month Return-60.42%-3.45%12.24%
1-Year Return427.78%5.62%30.9%
3-Year Return-98.27%3.8%30.19%
5-Year Return-99.72%39.68%91.72%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-200.00K469.80K2.07M2.80M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":7.15,"profit":true},{"date":"2021-12-31","value":16.8,"profit":true},{"date":"2022-12-31","value":73.95,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit-(200.00K)(469.80K)(2.07M)(2.80M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-20000000,"profit":false},{"date":"2021-12-31","value":-46980000,"profit":false},{"date":"2022-12-31","value":-206760000,"profit":false},{"date":"2023-12-31","value":-279590000,"profit":false}]
Gross Margin-(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses3.71M19.20M25.31M31.11M19.94M[{"date":"2019-12-31","value":11.91,"profit":true},{"date":"2020-12-31","value":61.7,"profit":true},{"date":"2021-12-31","value":81.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.08,"profit":true}]
Operating Income(3.71M)(19.20M)(25.74M)(31.11M)(19.94M)[{"date":"2019-12-31","value":-370540000,"profit":false},{"date":"2020-12-31","value":-1919690000,"profit":false},{"date":"2021-12-31","value":-2573570000,"profit":false},{"date":"2022-12-31","value":-3111430000,"profit":false},{"date":"2023-12-31","value":-1993930000,"profit":false}]
Total Non-Operating Income/Expense(45.00K)(6.60K)134.80K(3.78M)(2.86M)[{"date":"2019-12-31","value":-33.38,"profit":false},{"date":"2020-12-31","value":-4.9,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2806.53,"profit":false},{"date":"2023-12-31","value":-2123.29,"profit":false}]
Pre-Tax Income(3.73M)(19.20M)(25.59M)(34.73M)(20.95M)[{"date":"2019-12-31","value":-372790000,"profit":false},{"date":"2020-12-31","value":-1920020000,"profit":false},{"date":"2021-12-31","value":-2558870000,"profit":false},{"date":"2022-12-31","value":-3473100000,"profit":false},{"date":"2023-12-31","value":-2094930000,"profit":false}]
Income Taxes22.50K3.30K65.60K3.45M344.70K[{"date":"2019-12-31","value":0.65,"profit":true},{"date":"2020-12-31","value":0.1,"profit":true},{"date":"2021-12-31","value":1.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":9.99,"profit":true}]
Income After Taxes(3.75M)(19.20M)(25.65M)(38.18M)(21.29M)[{"date":"2019-12-31","value":-375040000,"profit":false},{"date":"2020-12-31","value":-1920350000,"profit":false},{"date":"2021-12-31","value":-2565430000,"profit":false},{"date":"2022-12-31","value":-3818120000,"profit":false},{"date":"2023-12-31","value":-2129400000,"profit":false}]
Income From Continuous Operations(3.73M)(19.20M)(25.59M)(34.73M)(20.95M)[{"date":"2019-12-31","value":-372790000,"profit":false},{"date":"2020-12-31","value":-1920020000,"profit":false},{"date":"2021-12-31","value":-2558870000,"profit":false},{"date":"2022-12-31","value":-3473100000,"profit":false},{"date":"2023-12-31","value":-2094930000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(3.75M)(19.20M)(25.65M)(38.18M)(21.29M)[{"date":"2019-12-31","value":-375040000,"profit":false},{"date":"2020-12-31","value":-1920350000,"profit":false},{"date":"2021-12-31","value":-2565430000,"profit":false},{"date":"2022-12-31","value":-3818120000,"profit":false},{"date":"2023-12-31","value":-2129400000,"profit":false}]
EPS (Diluted)(2.03)(5.27)(13.61)(39.75)-[{"date":"2019-12-31","value":-202.86,"profit":false},{"date":"2020-12-31","value":-526.89,"profit":false},{"date":"2021-12-31","value":-1361,"profit":false},{"date":"2022-12-31","value":-3975,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

KRBP
Cash Ratio 0.15
Current Ratio 0.22

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

KRBP
ROA (LTM) -119.42%
ROE (LTM) -1129.81%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

KRBP
Debt Ratio Lower is generally better. Negative is bad. 1.91
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.91

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

KRBP
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 11.55
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Kiromic Biopharma Inc share price today?

Kiromic Biopharma Inc (KRBP) share price today is $0.95

Can Indians buy Kiromic Biopharma Inc shares?

Yes, Indians can buy shares of Kiromic Biopharma Inc (KRBP) on Vested. To buy Kiromic Biopharma Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KRBP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Kiromic Biopharma Inc be purchased?

Yes, you can purchase fractional shares of Kiromic Biopharma Inc (KRBP) via the Vested app. You can start investing in Kiromic Biopharma Inc (KRBP) with a minimum investment of $1.

How to invest in Kiromic Biopharma Inc shares from India?

You can invest in shares of Kiromic Biopharma Inc (KRBP) via Vested in three simple steps:

  • Click on Sign Up or Invest in KRBP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Kiromic Biopharma Inc shares
What is Kiromic Biopharma Inc 52-week high and low stock price?

The 52-week high price of Kiromic Biopharma Inc (KRBP) is $3.78. The 52-week low price of Kiromic Biopharma Inc (KRBP) is $0.28.

What is Kiromic Biopharma Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Kiromic Biopharma Inc (KRBP) is

What is Kiromic Biopharma Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Kiromic Biopharma Inc (KRBP) is 11.55

What is Kiromic Biopharma Inc dividend yield?

The dividend yield of Kiromic Biopharma Inc (KRBP) is 0.00%

What is the Market Cap of Kiromic Biopharma Inc?

The market capitalization of Kiromic Biopharma Inc (KRBP) is $1.69M

What is Kiromic Biopharma Inc’s stock symbol?

The stock symbol (or ticker) of Kiromic Biopharma Inc is KRBP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top